CN112587562A - A Chinese medicinal composition - Google Patents
A Chinese medicinal composition Download PDFInfo
- Publication number
- CN112587562A CN112587562A CN202110000326.4A CN202110000326A CN112587562A CN 112587562 A CN112587562 A CN 112587562A CN 202110000326 A CN202110000326 A CN 202110000326A CN 112587562 A CN112587562 A CN 112587562A
- Authority
- CN
- China
- Prior art keywords
- parts
- fibrilia
- animal
- oil
- vegetable oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Physical Education & Sports Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition which is prepared from the following raw materials in parts by weight: the method comprises the following steps: 20-60 parts of fibrilia, 15-35 parts of vegetable oil, 20-28 parts of animal oil, 5-15 parts of lycopodium clavatum, 10-30 parts of radix angelicae pubescentis and 10-35 parts of salvia miltiorrhiza; the invention has the beneficial effects that: the invention adopts the mixture of vegetable oil and animal oil to increase the permeability and adhesive force of the medicine to the skin, especially the adhesive animal oil is sticky, and the allergic components of the patient in the formula are changed after the medicines are mixed, the content of the allergic components is reduced from 1.5 percent to 0.5 percent at present, and the medicine has special effect on knee synovitis, bony spur and meniscus tear.
Description
Technical Field
The invention relates to the field of traditional Chinese medicine products, in particular to a traditional Chinese medicine composition suitable for diseases such as lumbar disc herniation, cervical vertebra hyperosteogeny, knee hydrops, bony spur, synovitis, meniscus tear and the like.
Background
Under the condition of modern life, due to the acceleration of the pace of life and the fixation of the life mode, more and more people suffering from lumbar vertebra, cervical vertebra, knee and other bone diseases can suffer from pain in waist and lower extremities, numbness of hands and feet, even headache, dim eyesight and pain of serious people, loss of labor capacity and incapability of self-care of life, thereby causing great pain and difficulty to patients and families, and some families even return to poverty due to diseases.
At present, the method for treating the diseases at home and abroad generally adopts various methods such as massage traction, acupuncture, cupping, small needle knife, thread burying, ozone, electric melting, operation and the like, and is assisted with medicine treatment. The treatment by adopting the methods of traction, massage and acupuncture can only be temporarily relieved, can not be cured radically, and can even be aggravated in some cases, so that the time is wasted by patients and the focus is not completely eradicated; the operation treatment is a choice of the patients, but cervical vertebra, lumbar vertebra and knee joints all belong to important frameworks of human skeletons, and are intersected with nerves, so that the risk is very high, the operation is better than that of only removing the agaric from rotten wood, the environment for growing the agaric is not repaired and improved, the agaric is easy to relapse, and after the agaric relapses, the patients need to perform the operation again, so that the patients suffer pain and have little healing injury.
In view of the above-mentioned treatment methods, there are various inconveniences and side effects, and the patent of invention, patent No.: 201210137911.X patent, interest name: the invention discloses a Chinese medicine for treating lumbar disc herniation and cervical vertebra hyperosteogeny and a preparation method thereof, and discloses a Chinese medicine composition suitable for diseases such as lumbar disc herniation, cervical vertebra hyperosteogeny, hydrarthrosis, bony spur, synovitis, meniscus tear and the like, but the invention has the defects that: 1. 1-1.5% allergic persons; 2. the treatment effect on the patient with serious disease is slow.
Disclosure of Invention
In order to overcome the defects of the prior art, the invention aims to provide a traditional Chinese medicine composition.
The invention provides the following technical scheme:
a traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: the method comprises the following steps: 20-60 parts of fibrilia, 15-35 parts of vegetable oil, 20-28 parts of animal oil, 5-15 parts of lycopodium clavatum, 10-30 parts of radix angelicae pubescentis and 10-35 parts of salvia miltiorrhiza;
the preparation method comprises the following steps:
step A, firstly, bruising lycopodium clavatum, radix angelicae pubescentis and radix salviae miltiorrhizae, and grinding into medicinal powder for later use;
b, sequentially performing dust removal, cleaning and softening treatment on the fibrilia for later use;
step C, putting the medicinal powder obtained in the step A and the fibrilia obtained in the step B into animal and vegetable oil which is obtained by uniformly mixing vegetable oil and animal oil, soaking for 70-80 hours, and then kneading the soaked fibrilia for not less than 5 minutes, so that the medicinal powder is fully attached to the fibrilia, the animal and vegetable oil is fully soaked in the fibrilia, and the fibrilia is in a semi-dry state;
step D, arranging the fibrilia treated in the step C, and dividing the fibrilia into a plurality of groups, wherein 2-5 parts by weight of fibrilia attached with the medicinal powder is taken as one group, and each group is taken as one pair;
and E, respectively packaging the medicines in the step D in a moisturizing bag, and storing in an environment which is protected from light and has the temperature of 0-25 ℃ and the relative humidity of not less than 30%.
In the technical scheme, the health-care tea also comprises one or three of 2.5-7.5 parts of keel, 15-35 parts of sappan wood and 20-50 parts of myrobalan, and in the preparation step, in the step A, the lycopodium clavatum, the radix angelicae pubescentis, the root of red-rooted salvia, the keel, the sappan wood and the myrobalan are smashed and ground into medicinal powder for later use.
In the above technical scheme, the animal and vegetable oil is peanut oil or rapeseed oil.
In the above technical scheme, the animal oil is lard, beef tallow, mutton tallow.
In the above technical scheme, the particle size of the powder in step a is 30-40 mesh.
The invention has the beneficial effects that: the invention adopts the mixture of vegetable oil and animal oil to increase the permeability and adhesive force of the medicine to the skin, especially the adhesive animal oil is sticky, and the allergic components of the patient in the formula are changed after the medicines are mixed, the content of the allergic components is reduced from 1.5 percent to 0.5 percent at present, and the medicine has special effect on knee synovitis, bony spur and meniscus tear.
When the invention is used, the prepared medicine of the invention is taken and externally applied to the affected part of cervical vertebra or lumbar vertebra, then medical staff press the medicine with palm to carry out uninterrupted massage, so that the medicine can fully infiltrate into the focus part, and after the focus part fully absorbs the medicine, the focus part can be softened and lubricated, so that the protruded bone can be automatically reset, finally the hyperosteogeny disease can be completely cured without relapse. The invention has the characteristics of short treatment time, quick drug effect, thorough rehabilitation and low anaphylactic reaction rate in the treatment of lumbar disc herniation, cervical vertebra hyperosteogeny and complications thereof.
Detailed Description
The technical solutions of the present invention are described clearly and completely below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention discloses the following examples.
A Chinese medicinal composition: the raw material medicines of the invention have the following properties, flavors, meridians and efficacies:
lycopodium clavatum, bitter and pungent in flavor and warm in nature, recorded in Ben Cao Shi Yi (A supplement to materia Medica): bitter and pungent taste, warm and non-toxic. Enters liver, spleen and kidney meridians, and is mainly used for dispelling wind and cold, removing dampness and swelling, relaxing muscles and tendons and promoting blood circulation. It is indicated for arthralgia due to wind-cold-dampness, arthralgia, numbness of skin, weakness of limbs, edema, and traumatic injury.
The pubescent angelica has special fragrance, mild nature, bitter and pungent taste, slight numb tongue, and enters kidney channel and bladder channel, has the functions of dispelling wind, eliminating dampness, relieving arthralgia and stopping pain, and belongs to the wind-damp-dispelling cold-dispersing medicine classified under the wind-damp-dispelling medicines.
Salvia miltiorrhiza, which is slightly cold in nature and bitter in taste, enters heart and liver meridians and has the effects of removing blood stasis, relieving pain, promoting blood circulation, relieving dysmenorrhea, clearing heart fire and relieving restlessness. Belongs to the blood-activating and menstruation-regulating herbs classified under the blood-activating and stasis-resolving herbs, and is used for treating irregular menstruation, amenorrhea and dysmenorrhea, abdominal mass, thoracico-abdominal pain, heat arthralgia pain, sores and ulcers, pyogenic infections, vexation and insomnia; hepatosplenomegaly, angina pectoris.
Fructus Chebulae (Mongolian medicine, Altanarira) is dried golden mature fruit of Terminalia chebula of Combretaceae, and is selected when fruit is mature in autumn and winter. And (5) removing impurities of the yellow plump people, and drying in the shade. [ PROPERTIES ] astringent, sour, slightly bitter and mild. [ function and indication ] Xila, Yuan tiao, detoxification, digestion promotion, wound healing, granulation promotion, Huyi, Xila, Ba Da gan, Bao Ruan Da gan disease, trauma, fracture.
Lignum sappan (Mongolian medicine, named as broom cypress leaf and twig) is the dry core material of lignum sappan of Leguminosae, which can be collected all year round, removed white sapwood, and dried. (nature and taste) is sweet, salty and cool. [ function and indications ] clear blood heat, remove blood stasis, activate blood and dredge vessels.
Os Draconis (Mongolian medicine, Louis) is bone fossil of ancient mammals such as radix seu folium Mali Asiaticae, Rhinoceros, cattle, deer, elephant, etc., and is prepared by digging out, removing silt and impurities, and pulverizing and grinding. (nature and taste) sweet, astringent and cool. [ Functions and indications ] remove the adhesive, stop the stabbing pain, promote the generation of muscle, stop the decay, cure the wound and calm the nerves. Can be used for treating brain pain, intestinal pain, bone and muscle injury, fracture, metal injury, night sweat, insomnia, dreaminess, and Barbie disease.
Vegetable oils such as peanut oil, rapeseed oil; the animal oil is added into the components, so that the experimental dosage of the vegetable oil in the original formula is reduced, the oily feeling of the skin is reduced after the use, after the animal oil and the vegetable oil are matched with the component medicaments, the allergic components of patients in the formula are changed, the allergic rate after the medicament combination is reduced, the knee synovial membrane has a good effect, the vegetable oil is used for lubricating the skin, and the animal oil is used for bringing the medicament and is easier to permeate the skin.
Fibrilia is mainly used as attachments of lycopodium clavatum, pubescent angelica root, danshen root, myrobalan, dragon bone, sappan wood and animal and vegetable oil.
A traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: the method comprises the following steps: 20-60 parts of fibrilia, 15-35 parts of vegetable oil, 20-28 parts of animal oil, 5-15 parts of lycopodium clavatum, 10-30 parts of radix angelicae pubescentis, 10-35 parts of salvia miltiorrhiza, and one or three of 2.5-7.5 parts of keel, 15-35 parts of sappan wood and 20-50 parts of fructus terminaliae billericae;
the preparation method comprises the following steps:
step A, firstly, bruising common clubmoss herb, doubleteeth pubescent angilica root, danshen root, keel, sappan wood and myrobalan, and grinding the bruised common clubmoss herb, doubleteeth pubescent angilica root, danshen root, keel, sappan wood and myrobalan into medicinal powder for later use;
b, sequentially performing dust removal, cleaning and softening treatment on the fibrilia for later use;
step C, putting the medicinal powder obtained in the step A and the fibrilia obtained in the step B into animal and vegetable oil which is obtained by uniformly mixing vegetable oil and animal oil, soaking for 70-80 hours, and then kneading the soaked fibrilia for not less than 5 minutes, so that the medicinal powder is fully attached to the fibrilia, the animal and vegetable oil is fully soaked in the fibrilia, and the fibrilia is in a semi-dry state;
step D, arranging the fibrilia treated in the step C, and dividing the fibrilia into a plurality of groups, wherein 2-5 parts by weight of fibrilia attached with the medicinal powder is taken as one group, and each group is taken as one pair;
and E, respectively packaging the medicines in the step D in a moisturizing bag, and storing in an environment which is protected from light and has the temperature of 0-25 ℃ and the relative humidity of not less than 30%.
The following are specific embodiments:
scheme 1: the raw material medicines comprise the following components in parts by weight: 40 parts of fibrilia, 10 parts of lycopodium clavatum, 15 parts of radix angelicae pubescentis, 20 parts of salvia miltiorrhiza and 25 parts of animal and vegetable oil. The preparation method comprises the following steps: firstly, taking herba lycopodii, radix angelicae pubescentis and radix salviae miltiorrhizae, mashing and grinding into medicinal powder for later use; taking 40 parts of fibrilia, and carrying out dust removal, cleaning and softening treatment on the fibrilia for later use; soaking the above medicinal powder and fibrilia in 25 parts of animal and vegetable oil for 70-80 hr, and kneading the fibrilia for more than 5 min to make the medicinal powder fully adhere to the fibrilia, and fully soaking the animal and vegetable oil in the fibrilia, wherein the fibrilia is in semi-dry state; arranging the treated fibrilia, and cutting the fibrilia into a plurality of groups, wherein the fibrilia is attached with medicinal powder in 2-5 parts by weight as one group, and each group is one pair; then packaging the above materials in moisture keeping bag, and storing in dark environment at 0-25 deg.C and relative humidity of not less than 30%.
Scheme 2: the raw material medicines comprise the following components in parts by weight: 35 parts of fibrilia, 2 parts of keel, 18 parts of sappan wood, 12 parts of common clubmoss herb, 20 parts of doubleteeth pubescent angilica root, 25 parts of danshen root and 28 parts of vegetable oil. The preparation method comprises the following steps: mashing Os Draconis, lignum sappan, herba Lycopodii, radix Angelicae Pubescentis, and Saviae Miltiorrhizae radix; taking 35 parts of fibrilia, and carrying out dust removal, cleaning and softening treatment on the fibrilia for later use; soaking the above medicinal powder and fibrilia in 25 parts of animal and vegetable oil for 70-80 hr, and kneading the fibrilia for more than 5 min to make the medicinal powder fully adhere to the fibrilia, and fully soaking the animal and vegetable oil in the fibrilia, wherein the fibrilia is in semi-dry state; arranging the treated fibrilia, and cutting the fibrilia into a plurality of groups, wherein the fibrilia is attached with medicinal powder in 2-5 parts by weight as one group, and each group is one pair; then packaging the above materials in moisture keeping bag, and storing in dark environment at 0-25 deg.C and relative humidity of not less than 30%.
Scheme 3: the raw material medicines comprise the following components in parts by weight: 55 parts of fibrilia, 15 parts of lycopodium clavatum, 10 parts of radix angelicae pubescentis, 26 parts of salvia miltiorrhiza, 5 parts of keel, 20 parts of sappan wood, 45 parts of fructus terminaliae immaturus and 28 parts of vegetable oil. Firstly, taking herba lycopodii, radix angelicae pubescentis, salvia miltiorrhiza, keel, sappan wood and fructus terminaliae, mashing and grinding into medicinal powder for later use; taking 55 parts of fibrilia, and carrying out dust removal, cleaning and softening treatment on the fibrilia for later use; soaking the standby medicinal powder and fibrilia in 28 parts of animal and vegetable oil for 70-80 hours, and kneading the fibrilia for more than 5 minutes to ensure that the medicinal powder is fully attached to the fibrilia, the animal and vegetable oil is fully soaked in the fibrilia, and the fibrilia is in a semi-dry state; arranging the treated fibrilia, and cutting the fibrilia into a plurality of groups, wherein the fibrilia is attached with medicinal powder in 2-5 parts by weight as one group, and each group is one pair; then packaging the above materials in moisture keeping bag, and storing in dark environment at 0-25 deg.C and relative humidity of not less than 30%.
Scheme 4: the raw material medicines comprise the following components in parts by weight: 60 parts of fibrilia, 15 parts of lycopodium clavatum, 10 parts of radix angelicae pubescentis, 26 parts of salvia miltiorrhiza, 5 parts of dragon bone, 45 parts of myrobalan and 28 parts of vegetable oil. Firstly, taking herba lycopodii, radix angelicae pubescentis, salvia miltiorrhiza, keel, sappan wood and fructus terminaliae, mashing and grinding into medicinal powder for later use; 60 parts of fibrilia are taken, and the fibrilia is subjected to dust removal, cleaning and softening treatment for later use; soaking the standby medicinal powder and fibrilia in 28 parts of animal and vegetable oil for 70-80 hours, and kneading the fibrilia for more than 5 minutes to ensure that the medicinal powder is fully attached to the fibrilia, the animal and vegetable oil is fully soaked in the fibrilia, and the fibrilia is in a semi-dry state; arranging the treated fibrilia, and cutting the fibrilia into a plurality of groups, wherein the fibrilia is attached with medicinal powder in 2-5 parts by weight as one group, and each group is one pair; then packaging the above materials in moisture keeping bag, and storing in dark environment at 0-25 deg.C and relative humidity of not less than 30%.
In the scheme, according to the production scale, proper weight and multiple times can be selected according to the weight part ratio of each raw material in the example.
The following are the cases treated over the last two decades with the composition of scheme 4 of the present invention.
The following are treatment cases using the composition of scheme 4 of the present invention:
the above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the appended claims.
Claims (5)
1. A traditional Chinese medicine composition is characterized in that: the feed is prepared from the following raw materials in parts by weight: the method comprises the following steps: 20-60 parts of fibrilia, 15-35 parts of vegetable oil, 20-28 parts of animal oil, 5-15 parts of lycopodium clavatum, 10-30 parts of radix angelicae pubescentis and 10-35 parts of salvia miltiorrhiza;
the preparation method comprises the following steps:
step A, firstly, bruising lycopodium clavatum, radix angelicae pubescentis and radix salviae miltiorrhizae, and grinding into medicinal powder for later use;
b, sequentially performing dust removal, cleaning and softening treatment on the fibrilia for later use;
step C, putting the medicinal powder obtained in the step A and the fibrilia obtained in the step B into animal and vegetable oil which is obtained by uniformly mixing vegetable oil and animal oil, soaking for 70-80 hours, and then kneading the soaked fibrilia for not less than 5 minutes, so that the medicinal powder is fully attached to the fibrilia, the animal and vegetable oil is fully soaked in the fibrilia, and the fibrilia is in a semi-dry state;
step D, arranging the fibrilia treated in the step C, and dividing the fibrilia into a plurality of groups, wherein 2-5 parts by weight of fibrilia attached with the medicinal powder is taken as one group, and each group is taken as one pair;
and E, respectively packaging the medicines in the step D in a moisturizing bag, and storing in an environment which is protected from light and has the temperature of 0-25 ℃ and the relative humidity of not less than 30%.
2. A Chinese medicinal composition according to claim 1, wherein: the health-care tea also comprises one or three of 2.5-7.5 parts of dragon bone, 15-35 parts of sappan wood and 20-50 parts of fructus terminaliae immaturus, and in the preparation step, in the step A, the lycopodium clavatum, the radix angelicae pubescentis, the root of red-rooted salvia, the dragon bone, the sappan wood and the fructus terminaliae immaturus are smashed and ground into medicinal powder for later use.
3. A Chinese medicinal composition according to claim 1 or 2, wherein: the granularity of the Chinese medicine powder in the step A is 30-40 meshes.
4. A Chinese medicinal composition according to claim 3, wherein: the animal and vegetable oil is selected from peanut oil and rapeseed oil.
5. A Chinese medicinal composition according to claim 3, wherein: the animal oil is selected from lard, beef tallow, and mutton tallow.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110000326.4A CN112587562A (en) | 2021-01-03 | 2021-01-03 | A Chinese medicinal composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110000326.4A CN112587562A (en) | 2021-01-03 | 2021-01-03 | A Chinese medicinal composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112587562A true CN112587562A (en) | 2021-04-02 |
Family
ID=75206755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110000326.4A Pending CN112587562A (en) | 2021-01-03 | 2021-01-03 | A Chinese medicinal composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112587562A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113230298A (en) * | 2021-05-20 | 2021-08-10 | 乌兰托娅 | Traditional Chinese medicine for treating spinal cord compression, edema, vacuity symptom and demyelination and preparation method thereof |
| CN115282206A (en) * | 2022-08-10 | 2022-11-04 | 乌兰托娅 | Traditional Chinese medicine composition, preparation method and application thereof in preparation of medicine for treating hyperosteogeny |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102641321A (en) * | 2012-05-04 | 2012-08-22 | 乌兰托娅 | Traditional Chinese medicine for treating lumbar intervertebral disc herniation and cervical hyperplasia and preparation method thereof |
| CN103961596A (en) * | 2014-05-29 | 2014-08-06 | 张玉芳 | Traditional Chinese medicine for treating prolapse of lumbar intervertebral disc |
| CN106859970A (en) * | 2017-01-23 | 2017-06-20 | 安徽绿莹彩龙艾绒制药有限公司 | A kind of moxibustion shoulder encloses arthritic medicine moxa-moxibustion |
-
2021
- 2021-01-03 CN CN202110000326.4A patent/CN112587562A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102641321A (en) * | 2012-05-04 | 2012-08-22 | 乌兰托娅 | Traditional Chinese medicine for treating lumbar intervertebral disc herniation and cervical hyperplasia and preparation method thereof |
| CN103961596A (en) * | 2014-05-29 | 2014-08-06 | 张玉芳 | Traditional Chinese medicine for treating prolapse of lumbar intervertebral disc |
| CN106859970A (en) * | 2017-01-23 | 2017-06-20 | 安徽绿莹彩龙艾绒制药有限公司 | A kind of moxibustion shoulder encloses arthritic medicine moxa-moxibustion |
Non-Patent Citations (2)
| Title |
|---|
| 沈鸿，等: "羌活-独活在外用药活血散中的作用", 《中国实验方剂学杂志》 * |
| 陆红，等: "骨湿宁治疗风湿性关节炎的实验研究", 《中国现代应用药学》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113230298A (en) * | 2021-05-20 | 2021-08-10 | 乌兰托娅 | Traditional Chinese medicine for treating spinal cord compression, edema, vacuity symptom and demyelination and preparation method thereof |
| CN115282206A (en) * | 2022-08-10 | 2022-11-04 | 乌兰托娅 | Traditional Chinese medicine composition, preparation method and application thereof in preparation of medicine for treating hyperosteogeny |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102113599B (en) | Eucommia bark and honeysuckle tea and preparation method thereof | |
| CN102743730B (en) | Traditional Chinese medicine wine for treating arthritis and preparation method | |
| CN112587562A (en) | A Chinese medicinal composition | |
| CN1199668C (en) | Chinese-medicinal ointment for treating burn and scald and its preparing process | |
| CN105031408B (en) | A kind of composition improving gout | |
| KR20170143235A (en) | Herbal medicine composition for treatment of osteoarthritis and cartilage regeneration | |
| CN108635557A (en) | A kind of traditional Chinese medicine foot-bath powder and preparation method thereof | |
| CN114796162A (en) | Plaster for treating bone fracture and arthralgia and myalgia and preparation method thereof | |
| KR101769913B1 (en) | Diet patch and manufacturing method thereof | |
| KR20150122302A (en) | Herbal composition, method for producing therof and method for use therof | |
| CN106387232A (en) | Health-care tea with carbuncle treatment function | |
| CN102961633B (en) | A kind of preparation for being used to treat postpartum rheumatism | |
| CN103656219B (en) | Medicine for the treatment of wound and preparation method thereof | |
| CN111568986B (en) | Chinese medicinal oral prescription for setting fracture, external ointment and preparation method thereof | |
| CN107648659A (en) | A kind of marine alga Carbon fibe dressing, natural plaster and preparation method thereof | |
| CN102218094A (en) | Chinese medicinal preparation for treating traumatic injury and preparation method thereof | |
| CN1167451C (en) | Medicine for external application for curing scald and burn, its production method and application | |
| CN105687363A (en) | Special-effect traditional Chinese medicine for treating bleeding wounds and preparation method and application thereof | |
| CN1179730C (en) | Wound-treating external-use medicine | |
| CN105125926A (en) | Medical powder for treating burns and scalds and preparation method of medical powder | |
| CN104971120A (en) | Ointment for treating scab and preparation method | |
| CN107982341A (en) | A kind of Chinese medicine of orthopaedics therapy traumatic injury | |
| CN102631560B (en) | Medicine for treating lumbar disc herniation, and preparation method thereof | |
| CN114404503A (en) | Composition for treating rheumatic bone pain and traumatic injury, application and preparation method thereof | |
| CN116327680A (en) | External ginger paste and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210402 |
|
| RJ01 | Rejection of invention patent application after publication |